PT36 Real-World Analysis on Therapeutic Pattern and Economic Burden of Androgen-Receptor Signaling Inhibitors (ARSI) and Taxane-Based Chemotherapy Treated Metastatic Castration-Resistant Prostate Cancer Patients in Italy
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.2902
https://www.valueinhealthjournal.com/article/S1098-3015(23)06032-1/fulltext
Title :
PT36 Real-World Analysis on Therapeutic Pattern and Economic Burden of Androgen-Receptor Signaling Inhibitors (ARSI) and Taxane-Based Chemotherapy Treated Metastatic Castration-Resistant Prostate Cancer Patients in Italy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)06032-1&doi=10.1016/j.jval.2023.09.2902
First page :
Section Title :
Open access? :
No
Section Order :
12239